CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS
Clinical trials for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS explained in plain language.
Never miss a new study
Get alerted when new CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS trials appear
Sign up with your email to follow new studies for CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for sinus sufferers: drug targets stubborn inflammation
Symptom relief OngoingThis study tests an experimental drug called itepekimab in 66 adults with chronic sinusitis who have not improved with standard treatments. Participants receive either the drug or a placebo for 24 weeks. The goal is to see if itepekimab can reduce sinus inflammation and ease symp…
Matched conditions: CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS
Phase: PHASE2 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
New study digs into how mepolizumab changes nose bacteria and genes in asthma patients
Knowledge-focused OngoingThis study tracks 40 people with nasal polyps and severe asthma who are taking mepolizumab, a drug that reduces inflammation. Researchers collect nose, blood, and sputum samples before treatment and at 3, 6, and 12 months to see how the drug affects symptoms, nose bacteria, and g…
Matched conditions: CHRONIC RHINOSINUSITIS WITHOUT NASAL POLYPS
Sponsor: National and Kapodistrian University of Athens • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC